Literature DB >> 20385374

Altered cortical CDC42 signaling pathways in schizophrenia: implications for dendritic spine deficits.

Masayuki Ide1, David A Lewis.   

Abstract

BACKGROUND: Spine density on the basilar dendrites of pyramidal neurons is lower in layer 3, but not in layers 5 and 6, in the dorsolateral prefrontal cortex (DLPFC) of subjects with schizophrenia. The expression of CDC42 (cell division cycle 42), a RhoGTPase that regulates the outgrowth of the actin cytoskeleton and promotes spine formation, is also lower in schizophrenia; however, CDC42 mRNA is lower across layers 3-6, suggesting that other lamina-specific molecular alterations are critical for the spine deficits in the illness. The CDC42 effector proteins 3 and 4 (CDC42EP3, CDC42EP4) are preferentially expressed in DLPFC layers 2 and 3, and CDC42EP3 appears to assemble septin filaments in spine necks. Therefore, alterations in CDC42EP3 could contribute to the lamina-specific spine deficits in schizophrenia.
METHODS: We measured transcript levels of CDC42, CDC42EP3, CDC42EP4; their interacting proteins (septins [SEPT2, 3, 5, 6, 7, 8, and 11], anillin), and other spine-specific proteins (spinophilin, PSD-95, and synaptopodin) in the DLPFC from 31 subjects with schizophrenia and matched normal comparison subjects.
RESULTS: The expression of CDC42EP3 mRNA was significantly increased by 19.7%, and SEPT7 mRNA was significantly decreased by 6.9% in subjects with schizophrenia. Cortical levels of CDC42EP3 and SEPT7 mRNAs were not altered in monkeys chronically exposed to antipsychotic medications.
CONCLUSIONS: Activated CDC42 is thought to disrupt septin filaments transiently in spine necks, allowing the molecular translocations required for synaptic potentiation. Thus, altered CDC42 signaling via CDC42EP3 may perturb synaptic plasticity and contribute to the spine deficits observed in layer 3 pyramidal neurons in schizophrenia. Copyright 2010 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20385374      PMCID: PMC2900524          DOI: 10.1016/j.biopsych.2010.02.016

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  58 in total

1.  A new family of Cdc42 effector proteins, CEPs, function in fibroblast and epithelial cell shape changes.

Authors:  D S Hirsch; D M Pirone; P D Burbelo
Journal:  J Biol Chem       Date:  2001-01-12       Impact factor: 5.157

2.  Plasma membrane compartmentalization in yeast by messenger RNA transport and a septin diffusion barrier.

Authors:  P A Takizawa; J L DeRisi; J E Wilhelm; R D Vale
Journal:  Science       Date:  2000-10-13       Impact factor: 47.728

3.  Differential localization of septins in the mouse brain.

Authors:  A Kinoshita; M Noda; M Kinoshita
Journal:  J Comp Neurol       Date:  2000-12-11       Impact factor: 3.215

4.  The septin CDCrel-1 is dispensable for normal development and neurotransmitter release.

Authors:  Xiao-Rong Peng; Zhengping Jia; Yu Zhang; Jerry Ware; William S Trimble
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

5.  Borg proteins control septin organization and are negatively regulated by Cdc42.

Authors:  G Joberty; R R Perlungher; P J Sheffield; M Kinoshita; M Noda; T Haystead; I G Macara
Journal:  Nat Cell Biol       Date:  2001-10       Impact factor: 28.824

6.  Selective deficits in prefrontal cortex function in medication-naive patients with schizophrenia.

Authors:  D M Barch; C S Carter; T S Braver; F W Sabb; A MacDonald; D C Noll; J D Cohen
Journal:  Arch Gen Psychiatry       Date:  2001-03

7.  Reduced dorsal and orbital prefrontal gray matter volumes in schizophrenia.

Authors:  R E Gur; P E Cowell; A Latshaw; B I Turetsky; R I Grossman; S E Arnold; W B Bilker; R C Gur
Journal:  Arch Gen Psychiatry       Date:  2000-08

8.  Decreased somal size of deep layer 3 pyramidal neurons in the prefrontal cortex of subjects with schizophrenia.

Authors:  J N Pierri; C L Volk; S Auh; A Sampson; D A Lewis
Journal:  Arch Gen Psychiatry       Date:  2001-05

9.  No deficit in total number of neurons in the prefrontal cortex in schizophrenics.

Authors:  J J Thune; H B Uylings; B Pakkenberg
Journal:  J Psychiatr Res       Date:  2001 Jan-Feb       Impact factor: 4.791

10.  Functional analysis of a human homologue of the Drosophila actin binding protein anillin suggests a role in cytokinesis.

Authors:  K Oegema; M S Savoian; T J Mitchison; C M Field
Journal:  J Cell Biol       Date:  2000-08-07       Impact factor: 10.539

View more
  50 in total

1.  Cdc42 and Gsk3 modulate the dynamics of radial glial growth, inter-radial glial interactions and polarity in the developing cerebral cortex.

Authors:  Yukako Yokota; Tae-Yeon Eom; Amelia Stanco; Woo-Yang Kim; Sarada Rao; William D Snider; E S Anton
Journal:  Development       Date:  2010-12       Impact factor: 6.868

2.  Decreased protein S-palmitoylation in dorsolateral prefrontal cortex in schizophrenia.

Authors:  Anita L Pinner; Janusz Tucholski; Vahram Haroutunian; Robert E McCullumsmith; James H Meador-Woodruff
Journal:  Schizophr Res       Date:  2016-02-11       Impact factor: 4.939

Review 3.  Prefrontal cortical network connections: key site of vulnerability in stress and schizophrenia.

Authors:  Amy F T Arnsten
Journal:  Int J Dev Neurosci       Date:  2011-02-21       Impact factor: 2.457

4.  IQGAP1 regulates NR2A signaling, spine density, and cognitive processes.

Authors:  Can Gao; Shanti F Frausto; Anita L Guedea; Natalie C Tronson; Vladimir Jovasevic; Katie Leaderbrand; Kevin A Corcoran; Yomayra F Guzmán; Geoffrey T Swanson; Jelena Radulovic
Journal:  J Neurosci       Date:  2011-06-08       Impact factor: 6.167

Review 5.  Antipsychotic drug effects in schizophrenia: a review of longitudinal FMRI investigations and neural interpretations.

Authors:  C C Abbott; A Jaramillo; C E Wilcox; D A Hamilton
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

Review 6.  Developmental vulnerability of synapses and circuits associated with neuropsychiatric disorders.

Authors:  Peter Penzes; Andres Buonanno; Maria Passafaro; Carlo Sala; Robert A Sweet
Journal:  J Neurochem       Date:  2013-05-22       Impact factor: 5.372

7.  Molecular substrates of altered axonal growth and brain connectivity in a mouse model of schizophrenia.

Authors:  Jun Mukai; Makoto Tamura; Karine Fénelon; Andrew M Rosen; Timothy J Spellman; Rujun Kang; Amy B MacDermott; Maria Karayiorgou; Joshua A Gordon; Joseph A Gogos
Journal:  Neuron       Date:  2015-04-23       Impact factor: 17.173

8.  Altered Expression of ARP2/3 Complex Signaling Pathway Genes in Prefrontal Layer 3 Pyramidal Cells in Schizophrenia.

Authors:  Dibyadeep Datta; Dominique Arion; Kaitlyn M Roman; David W Volk; David A Lewis
Journal:  Am J Psychiatry       Date:  2016-08-13       Impact factor: 18.112

9.  Investigation of the involvement of MIR185 and its target genes in the development of schizophrenia.

Authors:  Andreas J Forstner; F B Basmanav; Manuel Mattheisen; Anne C Böhmer; Mads V Hollegaard; Esther Janson; Eric Strengman; Lutz Priebe; Franziska Degenhardt; Per Hoffmann; Stefan Herms; Wolfgang Maier; Rainald Mössner; Dan Rujescu; Roel A Ophoff; Susanne Moebus; Preben B Mortensen; Anders D Børglum; David M Hougaard; Josef Frank; Stephanie H Witt; Marcella Rietschel; Andreas Zimmer; Markus M Nöthen; Xavier Miró; Sven Cichon
Journal:  J Psychiatry Neurosci       Date:  2014-11       Impact factor: 6.186

Review 10.  Layer 3 Excitatory and Inhibitory Circuitry in the Prefrontal Cortex: Developmental Trajectories and Alterations in Schizophrenia.

Authors:  Gil D Hoftman; Dibyadeep Datta; David A Lewis
Journal:  Biol Psychiatry       Date:  2016-06-04       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.